Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.

The tuberculin skin test is one of the few tests developed in the 19th century that is still in present use in clinical medicine. The first tuberculin test material was prepared by Robert Koch (1); its use for detection of tuberculosis (TB) infection was first described in 1907 by von Pirquet (2). Given such a long history of use, it may seem surprising that aspects of interpretation of this test remain controversial. However, this reflects changes in the populations affected with tuberculosis and their relative frequency of true positive tests from TB infection, and false-positive tests associated with bacillus Calmette-Guerin (BCG) vaccination, or nontuberculous mycobacteria, as well as the recent human immunodeficiency virus (HIV) epidemic. Particular problems have arisen with use of repeated tuberculin tests to detect new infection in high-risk populations such as initially tuberculin-negative contacts of active cases, and workers with occupational exposure. This has revealed that tuberculin reactions may decrease in size (reversion) or increase in size because of: ( 1 ) random variability from differences in administration, reading, or biologic response; ( 2 ) immunologic recall of preexisting delayed type hypersensitivity to mycobacterial antigens (boosting); or ( 3 ) new infection (conversion). This review has been undertaken to provide information regarding factors causing changes in the size of repeated tuberculin reactions.

[1]  G. Comstock,et al.  Tuberculosis morbidity in the U.S. Navy: its distribution and decline. , 2015, The American review of respiratory disease.

[2]  G. Comstock,et al.  Tuberculin sensitivity eight to fifteen years after BCG vaccination. , 2015, The American review of respiratory disease.

[3]  J. Bearman,et al.  A STUDY OF VARIABILITY IN TUBERCULIN TEST READING. , 2015, The American review of respiratory disease.

[4]  J. Watters,et al.  Two-step tuberculin skin testing of injection drug users recruited from community-based settings. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[5]  T. McDonnell,et al.  Tuberculin sensitivity and the BCG scar in tuberculosis contacts. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  D. Snider,et al.  Boosting of tuberculin sensitivity among Southeast Asian refugees. , 1994, American journal of respiratory and critical care medicine.

[7]  R Menzies,et al.  The Booster Effect in Two-Step Tuberculin Testing among Young Adults in Montreal , 1994, Annals of Internal Medicine.

[8]  D. Amyot,et al.  Factors associated with tuberculin reactivity among the foreign-born in Montreal. , 1992, The American review of respiratory disease.

[9]  R Menzies,et al.  Effect of bacille Calmette-Guérin vaccination on tuberculin reactivity. , 1992, The American review of respiratory disease.

[10]  M. Demedts,et al.  Four-stage tuberculin testing in elderly subjects induces age-dependent progressive boosting. , 1992, Chest.

[11]  E. Perez-stable,et al.  Stability of positive tuberculin tests: are boosted reactions valid? , 1991, The American review of respiratory disease.

[12]  Lloyd N. Friedman,et al.  Diagnostic standards and classification of tuberculosis. , 1991, The American review of respiratory disease.

[13]  I. Strannegård,et al.  Sensitivity to sensitins and tuberculin in Swedish children. I. A study of schoolchildren in an urban area. , 1991, Tubercle.

[14]  R. Sorensen,et al.  The influence of Calmette-Guérin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. , 1990, The American review of respiratory disease.

[15]  P. D. march-Ayuela.  Choosing an appropriate criterion for true or false conversion in serial tuberculin testing. , 1990 .

[16]  C. A. van der Merwe,et al.  Random variation in tuberculin sensitivity in schoolchildren. Serial skin testing before and after preventive treatment for tuberculosis. , 1989, The American review of respiratory disease.

[17]  Karalus Nc.  Contact screening procedures for tuberculosis in Auckland. , 1988 .

[18]  T. To,et al.  Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons. , 1987, Annals of internal medicine.

[19]  T. To,et al.  The significance of the tuberculin skin test in elderly persons. , 1987, Annals of internal medicine.

[20]  M. Freundl,et al.  Two-stage skin testing for tuberculosis in a domiciliary population. , 1987, The American review of respiratory disease.

[21]  G. Bahr,et al.  Unexpected findings amongst the skin test responses to mycobacteria of BCG vaccinated Kuwaiti school children. , 1987, Tubercle.

[22]  E. Perez-stable,et al.  Time course and boosting of tuberculin reactions in nursing home residents. , 1986, The American review of respiratory disease.

[23]  T. Gross,et al.  Low prevalence of the booster phenomenon in nursing-home employees in Maryland. , 1986, Maryland medical journal.

[24]  E. Perez-stable,et al.  A demonstration of lack of variability among six tuberculin skin test readers. , 1985, American journal of public health.

[25]  S. Chaparas,et al.  Tuberculin test. Variability with the Mantoux procedure. , 1985, The American review of respiratory disease.

[26]  K. Hsu.  Tuberculin reaction in children treated with isoniazid. , 1983, American journal of diseases of children.

[27]  R. E. Hansen,et al.  High rate of tuberculin conversion in Indochinese refugees. , 1982, JAMA.

[28]  K. Nelson,et al.  Tuberculin test conversion during repeated skin testing, associated with sensitivity to nontuberculous mycobacteria. , 1979, The American review of respiratory disease.

[29]  Lyons Ha,et al.  Tuberculin sensitivity. Contacts of tuberculosis patients. , 1976 .

[30]  R. Narain,et al.  A fresh look at the definition of tuberculous infection and new infection. , 1976, The Indian journal of medical research.

[31]  J. Joncas,et al.  Interpretation of the PPD skin test in BCG-vaccinated children. , 1975, Canadian Medical Association journal.

[32]  C. Llewellyn,et al.  Skin testing for tuberculosis. Antigen and observer variability. , 1974, JAMA.

[33]  N. E. Mckinnon,et al.  Sensitivity to "atypical" acid-fast mycobacteria in Canada. , 1969, Canadian Medical Association journal.

[34]  C. Palmer,et al.  An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. , 1969, The American review of respiratory disease.

[35]  Veening Gj.  Long term isoniazid prophylaxis. Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults. , 1968 .

[36]  M. Furcolow,et al.  A comparison of the tine and Mono-Vacc tests with the intradermal tuberculin test. , 1967, The American review of respiratory disease.

[37]  C. Palmer,et al.  Experimental and epidemiologic basis for the interpretation of tuberculin sensitivity. , 1959, The Journal of pediatrics.

[38]  A. Wallgren.  The time-table of tuberculosis. , 1948, Tubercle.

[39]  C. Pirquet.  FREQUENCY OF TUBERCULOSIS IN CHILDHOOD , 1909 .

[40]  R. Koch.  An Address on Bacteriological Research , 1890, British medical journal.

[41]  C. Macintyre,et al.  Preventability of incident cases of tuberculosis in recently exposed contacts. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[42]  C. Dacso.  Skin Testing for Tuberculosis , 1990 .

[43]  E. Perez-stable,et al.  Evaluation of a third sequential tuberculin skin test in a chronic care population. , 1988, The American review of respiratory disease.

[44]  K. Stýblo,et al.  Results of contact examination in Rotterdam, 1967-1969. , 1975, Bulletin of the International Union against Tuberculosis.

[45]  S. Grzybowski,et al.  Contacts of cases of active pulmonary tuberculosis. , 1975, Bulletin of the International Union against Tuberculosis.

[46]  O. Horwitz,et al.  Correlation between tuberculin sensitivity after 2 months and 5 years among BCG vaccinated subjects. , 1972, Bulletin of the World Health Organization.

[47]  V. Houk,et al.  The eradication of tuberculosis infection by isoniazid chemoprophylaxis. , 1968, Archives of environmental health.

[48]  O. Wasz-Hockert.  On the period of incubation in tuberculosis. , 1947, Annales medicinae internae Fenniae.

[49]  A. W. Dahlstrom.  The Instability of the Tuberculin Reaction. Observations on Dispensary Patients with Special Reference to the Existence of Demonstrable Tuberculous Lesions and the Degree of Exposure to Tubercle Bacilli. , 1940 .